HomeTagsAGAMREE

AGAMREE

Santhera Expands Biomedica Agreement to Extend AGAMREE (Vamorolone) Distribution Across Central Asia and the Caucasus

Vamorolone (Agamree) Rejected by INESSS: When Cost Takes Priority Over Compassion in DMD Care

Vamorolone (Agamree) in DMD: Real-World Experience

Santhera Announces Proposed Inclusion and Reimbursement of AGAMREE (Vamorolone) within Spain’s National Health System for the Treatment of Duchenne Muscular Dystrophy

AGAMREE (Vamorolone) has been approved in Switzerland by Swissmedic

Nxera Pharma Licenses Japan and Select Asia-Pacific Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals

Five-Year Data of AGAMREE (vamorolone) in Patients with DMD Show Improved Safety Profile with Comparable Effectiveness to Standard of Care Corticosteroids

Santhera Secures Agreement with Biomedica for the Distribution of AGAMREE (Vamorolone) in Russia

Health Canada Approves AGAMREE (vamorolone) as the First Treatment for Duchenne Muscular Dystrophy in Canada

12 3 Page 1 of 3

Popular

Frequently Asked Questions About Elevidys Used for DMD

Can Ekinci - August 21, 2026

Must Read

Del-Zota SAFARI44 Phase 3 Trial: A New Exon 44 Skipping Study for Duchenne Muscular Dystrophy

RGX-202 Duchenne Gene Therapy Shows NSAA Improvement and Microdystrophin Expression — But Important Biomarker Data Missing

CRISPR GuideX Tool: hfCas12Max in CRISPR-Based Therapeutics

About us

Together, we will keep fighting for better treatments and access for everyone with Duchenne.

Powered by Hostinger

Latest Articles

Beyond Micro-Dystrophin: Could Full-Length Dystrophin Be the Next Step in DMD Gene Therapy?

Research September 3, 2026 0

Renzhi Han, PhD, at Indiana University is advancing a...

NewBiologix and Synastra Partner to Advance DMD Gene Therapy Manufacturing

Press Releases September 2, 2026 0

A new international collaboration is bringing together biotechnology expertise...

What Is Exon Deletion? Understanding Exon Deletions in Duchenne Muscular Dystrophy

DMD September 2, 2026 0

What is exon deletion, and why does it matter...

Most Popular

Frequently Asked Questions About Elevidys Used for DMD

Approved Therapies August 21, 2026 0

Duchenne muscular dystrophy (DMD) is a genetic condition that...

Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy

Editorials April 10, 2026 0

The landscape of potential new gene therapies for Duchenne...

The Brutal Truth: Why Duchenne Muscular Dystrophy Treatment Costs Are Out of Control

Editorials April 6, 2026 0

The duchenne muscular dystrophy treatment cost has become one...

© 2024 - 2026 DMD Warrior. All rights reserved.